4//SEC Filing
Recro Pharma, Inc. 4
Accession 0001123292-17-000215
CIK 0001588972operating
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 3:49 PM ET
Size
7.7 KB
Accession
0001123292-17-000215
Insider Transaction Report
Form 4
McCallum Stewart
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2017-01-18+36,000→ 36,000 totalExercise: $7.33Exp: 2027-01-18→ Common Stock (36,000 underlying) - Award
Restricted Stock Units
2017-01-18+24,000→ 24,000 total→ Common Stock (24,000 underlying)
Footnotes (3)
- [F1]The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
- [F3]The restricted stock units vest in four equal annual installments beginning January 18, 2018. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date.
Documents
Issuer
Recro Pharma, Inc.
CIK 0001588972
Entity typeoperating
IncorporatedPA
Related Parties
1- filerCIK 0001588972
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 3:49 PM ET
- Size
- 7.7 KB